Liang Jeff, Rastegar Ryan, El Helou Mohamad, Mathur Kushagra, Larson Brent K, Waters Kevin, Vasireddy Anila, Randhawa Navikran, Mubarak Muhammad, Advani Rashmi, Osipov Arsen, Gong Jun, Hendifar Andrew, Liu Quin, Park Kenneth H, Watson Rabindra, Pandol Stephen J, Lo Simon, Gaddam Srinivas
Cedars-Sinai Health Systems, Los Angeles, California, USA.
University of California Los Angeles, Los Angeles, California, USA.
Am J Gastroenterol. 2025 Apr 1;120(4):890-904. doi: 10.14309/ajg.0000000000003068. Epub 2024 Sep 3.
Upper gastrointestinal (UGI) cancers, comprising malignancies of the esophagus, stomach, duodenum, pancreas, liver, biliary tract, and gallbladder, are the second leading cause of cancer-related mortality in the United States and are associated with significant comorbidities. Recent studies show a disproportionate rise in pancreatic and stomach cancer among young adults. This study aims to use a nationwide, population-based cohort to (i) evaluate the trend of all UGI cancer as an aggregate and (ii) examine the role of demographics, histology, and tumor stage in UGI cancer incidence among young adults.
Individuals diagnosed with UGI cancer in the United States from 2001 to 2019 were identified and obtained from the Surveillance, Epidemiology, and End Results-National Program of Cancer Registries database. The primary outcomes were incidence rates of UGI cancer (calculated per 100,000, age-adjusted to the year 2000 US population), stratified by sex and age (< 55 years for young adults and ≥ 55 years for older adults). Trends, annual percentage change, and average annual percentage change were calculated using the parametric method. Sensitivity analysis was performed according to primary site and histology; further analysis examining race and cancer stage was performed in the young adult subgroup.
A total of 2,333,161 patients with UGI cancer were identified. Most cases were male, and 14.3% were < 55 years of age. Incidence of UGI cancer increased most in women younger than 55 years, driven primarily by pancreatic and stomach cancers, as well as neuroendocrine tumor and gastrointestinal stromal tumor histology. African American race and localized tumors and malignancy with distant spread are also contributing to the disparate increase among young women. UGI mortality rates have not changed significantly in young adults.
The overall incidence rate of upper gastrointestinal cancer is increasing significantly in young women compared with men. Increased endoscopic procedures and disparate exposure to risk factors are likely contributing to these trends.
上消化道(UGI)癌症包括食管、胃、十二指肠、胰腺、肝脏、胆道和胆囊的恶性肿瘤,是美国癌症相关死亡的第二大主要原因,且与严重的合并症相关。最近的研究表明,年轻成年人中胰腺癌和胃癌的发病率上升幅度不成比例。本研究旨在利用全国性的、基于人群的队列来(i)评估所有UGI癌症作为一个整体的趋势,以及(ii)研究人口统计学、组织学和肿瘤分期在年轻成年人UGI癌症发病率中的作用。
从监测、流行病学和最终结果-国家癌症登记计划数据库中识别并获取2001年至2019年在美国被诊断为UGI癌症的个体。主要结局是UGI癌症的发病率(按每10万人计算,并根据2000年美国人口进行年龄调整),按性别和年龄分层(年轻成年人<55岁,老年人≥55岁)。使用参数方法计算趋势、年度百分比变化和平均年度百分比变化。根据主要部位和组织学进行敏感性分析;在年轻成年人亚组中进行了进一步的种族和癌症分期分析。
共识别出2333161例UGI癌症患者。大多数病例为男性,14.3%的患者年龄<55岁。55岁以下女性的UGI癌症发病率上升最为显著,主要由胰腺癌、胃癌以及神经内分泌肿瘤和胃肠道间质瘤组织学驱动。非裔美国人种族以及局限性肿瘤和远处转移的恶性肿瘤也导致了年轻女性中发病率的差异增加。年轻成年人的UGI死亡率没有显著变化。
与男性相比,年轻女性中上消化道癌症的总体发病率显著上升。内镜检查的增加和对危险因素的不同暴露可能是导致这些趋势的原因。